Affiliation:
1. Biomedical Center, Qingdao University, No. 308 Ningxia Road, Qingdao 266021, China
2. Department of Epidemiology and Health Statistics, Public Health College, Qingdao University, No. 308 Ningxia Road, Qingdao 266021, China
Abstract
Background: Women with polycystic ovary syndrome (PCOS) have increased odds of concurrent depression, indicating that the relationship between PCOS and depression is more likely to be comorbid. However, the underlying mechanism remains unclear. Here, we aimed to use bioinformatic analysis to screen for the genetic elements shared between PCOS and depression. Methods: Differentially expressed genes (DEGs) were screened out through GEO2R using the PCOS and depression datasets in NCBI. Protein–protein interaction (PPI) network analysis and enrichment analysis were performed to identify the potential hub genes. After verification using other PCOS and depression datasets, the associations between key gene polymorphism and comorbidity were further studied using data from the UK biobank (UKB) database. Results: In this study, three key genes, namely, SNAP23, VTI1A, and PRKAR1A, and their related SNARE interactions in the vesicular transport pathway were identified in the comorbidity of PCOS and depression. The rs112568544 at SNAP23, rs11077579 and rs4458066 at PRKAR1A, and rs10885349 at VTI1A might be the genetic basis of this comorbidity. Conclusions: Our study suggests that the SNAP23, PRKAR1A, and VTI1A genes can directly or indirectly participate in the imbalanced assembly of SNAREs in the pathogenesis of the comorbidity of PCOS and depression. These findings may provide new strategies in diagnosis and therapy for this comorbidity.
Funder
Shandong Province Medical and Health Technology Development Fund
Reference55 articles.
1. PCOS and Depression: Common Links and Potential Targets;Kolhe;Reprod. Sci.,2022
2. Hormonal, genetic, epigenetic and environmental aspects of polycystic ovarian syndrome;Bhandary;Gene Rep.,2022
3. Depression, anxiety, body image scores, and sexual dysfunction in patients with polycystic ovary syndrome according to phenotypes;Altuntas;Gynecol. Endocrinol.,2022
4. Depression and anxiety in women with polycystic ovarian syndrome: A literature survey;Zehravi;Int. J. Adolesc. Med. Health,2021
5. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: A systematic review and meta-analysis;Cooney;Hum. Reprod.,2017